These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 35297303)
1. Collagen type IV alpha 1 (COL4A1) silence hampers the invasion, migration and epithelial-mesenchymal transition (EMT) of gastric cancer cells through blocking Hedgehog signaling pathway. Cui X; Shan T; Qiao L Bioengineered; 2022 Apr; 13(4):8972-8981. PubMed ID: 35297303 [TBL] [Abstract][Full Text] [Related]
2. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells. Zhang H; Wang Y; Ding H Clin Transl Oncol; 2021 Oct; 23(10):2078-2089. PubMed ID: 33891266 [TBL] [Abstract][Full Text] [Related]
3. Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells. Zeng C; Yan R; Yang G; Xiang S; Zhao F Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32478377 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of DDR1 Promotes Migration, Invasion, Though EMT-Related Molecule Expression and COL4A1/DDR1/MMP-2 Signaling Axis. Xie X; He H; Zhang N; Wang X; Rui W; Xu D; Zhu Y Technol Cancer Res Treat; 2020; 19():1533033820973277. PubMed ID: 33234027 [TBL] [Abstract][Full Text] [Related]
5. miR-375-3p/YWHAZ/β-catenin axis regulates migration, invasion, EMT in gastric cancer cells. Guo F; Gao Y; Sui G; Jiao D; Sun L; Fu Q; Jin C Clin Exp Pharmacol Physiol; 2019 Feb; 46(2):144-152. PubMed ID: 30353914 [TBL] [Abstract][Full Text] [Related]
6. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition]. Zuo X; Cai J; Chen Z; Li Y; Zhang D Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577 [TBL] [Abstract][Full Text] [Related]
7. Dual activation of Hedgehog and Wnt/β-catenin signaling pathway caused by downregulation of SUFU targeted by miRNA-150 in human gastric cancer. Peng Y; Zhang X; Lin H; Deng S; Qin Y; He J; Hu F; Zhu X; Feng X; Wang J; Wei Y; Fan X; Lin H; Ashktorab H; Smoot D; Lv Y; Li S; Meltzer SJ; Jin Z Aging (Albany NY); 2021 Apr; 13(7):10749-10769. PubMed ID: 33848981 [TBL] [Abstract][Full Text] [Related]
8. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway. Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510 [TBL] [Abstract][Full Text] [Related]
9. MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway. Ma F; Yao J; Niu X; Zhang J; Shi D; Da M Pathol Res Pract; 2024 Sep; 261():155471. PubMed ID: 39079384 [TBL] [Abstract][Full Text] [Related]
10. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1. Liu L; Tian YC; Mao G; Zhang YG; Han L Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797 [TBL] [Abstract][Full Text] [Related]
11. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition. Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484 [TBL] [Abstract][Full Text] [Related]
13. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer. Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001 [TBL] [Abstract][Full Text] [Related]
14. Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis. Xu XF; Wang JJ; Ding L; Ye JS; Huang LJ; Tao L; Gao F; Ji Y J Cell Biochem; 2019 Jan; 120(1):439-451. PubMed ID: 30216523 [TBL] [Abstract][Full Text] [Related]
15. LncRNA SND1-IT1 facilitates TGF-β1-induced epithelial-to-mesenchymal transition via miR-124/COL4A1 axis in gastric cancer. Hu YZ; Hu ZL; Liao TY; Li Y; Pan YL Cell Death Discov; 2022 Feb; 8(1):73. PubMed ID: 35184134 [TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer. Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464 [TBL] [Abstract][Full Text] [Related]
17. SMC1A facilitates gastric cancer cell proliferation, migration, and invasion via promoting SNAIL activated EMT. Liu Y; Fang X; Wang Q; Xiao D; Zhou T; Kang K; Peng Z; Ren F; Zhou J BMC Gastroenterol; 2023 Aug; 23(1):268. PubMed ID: 37537540 [TBL] [Abstract][Full Text] [Related]
18. RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/STAT3 to Promote Invasion and Metastasis in Gastric Cancer. Ma Z; Sun Q; Zhang C; Zheng Q; Liu Y; Xu H; He Y; Yao C; Chen J; Xia H Int J Biol Sci; 2023; 19(14):4411-4426. PubMed ID: 37781036 [No Abstract] [Full Text] [Related]
19. MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1. Cao JM; Li GZ; Han M; Xu HL; Huang KM Biomed Pharmacother; 2017 Sep; 93():554-560. PubMed ID: 28686969 [TBL] [Abstract][Full Text] [Related]
20. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling. Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]